Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

Study Coordinator: Tariq Syed

Status: Enrolling Number: NCT05813275

Phone: 346.238.6466

Protocol Number: PRO00037801


This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare aFixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
More to Explore